WHO Announces Approval of Indian Covovax Vaccine

First modification: 17/12/2021 – 16:16

–

Ginebra (AFP) – The World Health Organization (WHO) announced this Friday that it certified the Indian coronavirus vaccine Covovax.

This vaccine “is produced by the Serum Institute of India under license from Novovax and is part of the portfolio of Covax (international system for the distribution of vaccines against covid-19), which will boost efforts to vaccinate more people in the countries low-income “, highlighted the WHO.

“Vaccines continue to be one of the most effective methods of protection against serious forms and death caused by SARS-COV-2, despite the emergence of new variants,” stressed Dr. Mariangela Simao, in charge of access to medicines from The OMS.

This approval “should facilitate access to vaccines to poor countries, 41 of which have not yet been able to vaccinate 10% of their population, while 98% of countries have not yet reached 40%,” he stressed.

WHO had set a goal of vaccinating 40% of the population in all countries by the end of the year.

This vaccine requires two doses and can be stored at temperatures of 2 to 8 °, like commercial refrigerators have it.

© 2021 AFP

–